Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Proportion of TB case contacts with micronutrient deficiency at baseline by follow-up IGRA status   | IGRA converter (n=115) N (%) | Persistently IGRA negative(n=315) N (%) | Total N (%) | p: 25-OH vitamin D<50 nmol/L | 48 (41.7) | 133 (42.4) | 181 (42.2) | 0.91

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This cohort study in Bandung, Indonesia, followed Interferon Gamma Release Assay (IGRA) negative TB case contacts with a repeat IGRA test at 3 mo.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Micronutrient status and risk of Mycobacterium tuberculosis infection in Indonesian tuberculosis case contacts

Cohort study · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2025

Original publication title

Micronutrient status and risk of Mycobacterium tuberculosis infection in Indonesian tuberculosis case contacts

Ayesha J Verrall; Lisa Houghton; Lika Apriani; Harold E Atmaja; Arjan van Laarhoven; James E Ussher; Rovina Ruslami; Katrina Sharples; Susan McAllister; Reinout van Crevel; Philip C Hill; Bachti Alisjahbana

© The Author(s) 2025. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The risk of developing M.tb infection, as defined by IGRA conversion, is associated with increasing ferritin. Interventions in TB case contacts to temporarily reduce iron levels, including considering withholding any iron supplementation, may be worthy of evaluation.

An extract from the source publication. Read it in context.

At a glance

Study background

What background does the paper provide?

Historic observations suggest susceptibility to TB disease is influenced by host nutrition. For example, an x-ray survey in a German Prisoner of War camp found British prisoners, who received Red Cross rations, had a much lower rate of TB disease than Russians who did not (1.2% vs 19.0%).1 An analysis of data from a nutritional and social intervention for children in the preantibiotic era that provided stable employment, housing and nutrition for patients with TB and their families (the Papworth experiment) showed a reduction in TB disease.2

There has been very little research on the influence of nutritional status on the development of Mycobacterium tuberculosis (M.tb) infection after household exposure to a TB case. We previously reported that the risk of a new infection, defined as Interferon Gamma Release Assay (IGRA) conversion, increased 14% with every g/dL increase in haemoglobin at the time of initial screening (95% CI 1 to 30%; p=0.04).3 Iron has been shown to be important for the growth of M.tb;4 an intervention trial of vitamin D supplementation showed a minimal reduction in tuberculin skin test conversion;5 and a case control study in Peru reported an increased risk of vitamin A deficiency and TB disease.6 However, evidence of the impact of giving vitamin A or other micronutrients on the risk of developing M.tb infection is scarce.

In the present study, we therefore investigated whether any of the five micronutrients (iron, zinc, selenium, vitamin A and vitamin D) were associated with the risk of developing M.tb infection.

Source: Introduction Source: Introduction Source: Introduction

Study methods

What methods does the paper describe?

Study design and procedures

This cohort study followed IGRA-negative TB case contacts, aged over 5 y, of sputum smear positive TB patients in the ‘INFECT’ study platform in Bandung, Indonesia, as previously described.3 Index case characteristics were recorded and their M.tb isolates obtained. Contacts’ demographic characteristics, smoking status, medical history, symptoms and measures of exposure to respective index cases were recorded. Physical examination included assessment of a Bacillus Calmette-Guerin (BCG) vaccination scar, height and weight. Contacts underwent a QuantiFERON-TB Gold In-Tube IGRA test for M.tb infection, interpreted according to the manufacturer's instructions.

Contacts who were IGRA negative at baseline had a repeat IGRA at 14 wk, whereupon they were labelled as IGRA ‘converters’ or ‘persistently negative’. Associations of anthropometric results with IGRA conversion have been reported previously.3

Blood was drawn into a trace element-free evacuated tube (Becton Dickinson) following the International Zinc Nutrition Consultative Group procedures.7 Time of blood collection and time of the last meal were recorded before immediate transfer of the blood samples to a chilled container (−4°C) for transport to the base laboratory. Here serum was separated using trace element-free techniques,7 and aliquots frozen at −80°C before analysis or shipment on dry ice to the Department of Human Nutrition, University of Otago, New Zealand, for biomarker analysis of zinc, selenium and vitamin D, and to the laboratory of Dr J Erhardt (VitMins Laboratory, Germany) for biomarker analysis of vitamin A retinol-binding protein (RBP), iron and inflammation markers.

Haemoglobin was determined by means of a complete blood count using an automated counter (Sysmex XE 5000; Sysmex Corporation).

Laboratory procedures

Serum vitamin D (as a 25-hydroxyvitamin D) was measured by the validated bioanalytical method8 using liquid chromatography-tandem mass spectrometer (LC-MS/MS) at the Pharmocokinetic laboratory, Faculty of Medicine, Universitas Padjadjaran, Bandung. Serum 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 concentration were determined by isotope-dilution LC-MS/MS.8 In brief, 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 internal standards were reconstituted to working concentrations using spectrophotometry. Frozen serum samples were thawed, denatured with methanol-propanol containing internal standard, vortex-mixed, extracted into hexane and dried under nitrogen. The reconstituted extract was analysed by chromatography on a Base Deactivated Silica C8 High-performance liquid chromatography column, and the metabolites and internal standards were detected by electrospray ionization MS/MS in multiple-reaction monitoring mode on a Waters instrument.

Each batch contained four UTAK controls containing known concentrations of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in pooled serum sample (SRM 972, USNIST). The coefficients of variation (CV) for UTAK controls were 4% for 25-hydroxyvitamin D3 medium, 8% for 25-hydroxyvitamin D3 low, 5% for 25-hydroxyvitamin D2 medium and 11% for 25-hydroxyvitamin D2 low.

Serum was analysed in duplicate in the laboratory of Dr J Erhardt (VitMins Laboratory, Germany) for iron biomarkers ferritin and serum transferrin receptor (sTfR), vitamin A biomarker RBP, and inflammation markers C-reactive protein (CRP) and alpha-1-acid glycoprotein (AGP), by a combined sandwich ELISA technique.9 Interassay CV of a control sample (n=40) were 2.3% for ferritin, 3.6% for sTfR, 3.6% for RBP, 5.8% for CRP and 8.1% for AGP. Serum zinc and selenium were analysed by inductively coupled plasma MS (ICP-MS) (Agilent 7500ce ICP-MS; Agilent Technologies) at the University of Otago, New Zealand.

The CV for a pooled sample (n=20) and control (UTAK, Utak Laboratories Inc.; n=41) for both zinc and selenium were 1.1% and 2.3%, respectively, with the mean results for the UTAK control both within 3% of certified values.

Statistical analysis

Descriptive statistics (median and IQR or number and %) were used to describe index case and contact demographic and clinical characteristics, anthropometric measures and biomarker concentrations. Zinc values were adjusted for time since last meal, time of sample collection and time from collection to separation (in keeping with evidence of the sensitivity of zinc levels to these factors),10 using a linear regression model with ln(Zn) as the dependent variable and logged time variables as independent variables. Following this, serum ferritin, sTfR, selenium, zinc and RBP values were adjusted for the confounding effects of inflammation (with CRP and AGP), using the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia regression approach.11 Briefly, biomarkers were transformed to meet the assumptions for linear regression (loge all except ferritin, where a square root transformation was used).

A linear regression model with the transformed biomarker as the dependent variable and ln(CRP) and ln(AGP) as the independent variables was used.12 The regression coefficients of ln(CRP) and ln(AGP) were then used to calculate adjusted values of the biomarkers using a reference concentration (maximum of lowest decile) for serum CRP and AGP to avoid overadjusting the micronutrient biomarkers among individuals with low levels of inflammation. Total body iron (TBI), expressed as mg/kg body weight, was calculated using the logarithm of the ratio of adjusted sTfR to adjusted serum ferritin (SF) as follows:: [log(sTfR/SF): 2.28229]/0.1207.13

Means and 95% CIs were calculated, where appropriate, for vitamin D and adjusted concentrations for serum ferritin, sTfR, RBP, TBI, zinc and selenium.

The thresholds for defining suboptimal biomarkers were as follows (using measures adjusted for inflammation): serum ferritin <12 μg/l;14 sTfR >8.3 mg/l;9 RBP <0.83 μmol/l;15 serum zinc <9.9 μmol/l;16 and serum selenium ≤0.82 μmol/l;17 25-hydroxyvitamin D <50 nmol/l;18 TBI deficiency <0 mg/kg. Inflammation was assessed by serum CRP >5 mg/L and AGP >1 g/L, respectively.19

Associations between case contact micronutrient concentration and IGRA conversion were estimated as relative risks using Poisson regression generalised estimating equations, clustering on case.20 Robust standard errors account for the clustering in the data and the non-Poisson errors. Observations for each micronutrient variable were scaled by dividing by the overall SD for that variable. The form of the relationships were first examined using fractional polynomial models.21 Separate multivariate models were then fit for all the three measures of iron status (ferritin, sTfR and TBI).

Only the iron biomarker that explained the highest amount of the variance (R2) with IGRA conversion was included in the final multivariate model to avoid issues with multicollinearity. Initial multivariable models included known non-nutritional potential confounders (age and gender of index case and contacts, BCG vaccination, body mass index [BMI], smoking, diabetes), as well as a score reflecting degree of exposure to TB. The score was the predicted value from logistic regression of M.tb exposure variables (index case: sputum smear grade, cavities, extent of radiographic disease; contacts: hours spent with, and sleeping proximity to, the case) against IGRA results.

Model selection was performed using modified backwards selection, with age and gender of case and contact retained.

All analyses were carried out using Stata version 17 (StataCorp LLC. College Station, TX). p<0.05 (two-sided) indicated statistical significance.

Source: Methods Source: Methods Source: Methods

Discussion

To the best of our knowledge, this is the first study investigating multiple micronutrient status and risk of developing M.tb infection. Our findings show that, in addition to the previously identified association of increasing haemoglobin with IGRA conversion, there is also a positive association for ferritin. There were no associations found between zinc, selenium, vitamin A or vitamin D status and IGRA conversion.

The association of increasing ferritin with IGRA conversion is consistent with studies that have demonstrated iron is a nutritional requirement of M.tb infection.4 We also note that, with respect to TB disease, the iron transporter natural resistance-associated macrophage protein (NRAMP) is strongly associated with susceptibility.22 In a Tanzanian study, high plasma ferritin was associated with increased treatment failure in TB cases and low ferritin levels were associated with increased mortality.23 Increasing hepcidin, a regulator of iron homeostasis, levels correlated with increasing time to culture negativity in Japanese TB cases.24 Together, these findings indicate that increased availability of iron increases the capacity of M.tb to cause infection as well as disease, consistent with the pathogen's nutritional dependency on iron.

We found no association with IGRA conversion for the remaining micronutrients investigated. However, there is some reason to believe that other micronutrient supplementation may have a role in relation to both M.tb infection and disease, at least in certain situations. An intervention trial in vitamin D-deficient children in Mongolia showed a borderline significant reduction in tuberculin skin test conversion over 6 mo: five (11%) children receiving vitamin D supplementation underwent conversion compared with 11 (27%) receiving placebo (RR 0.41; 95% CI 0.16 to 1.09; p=0.06).5 Vitamin A and selenium deficiencies have been associated with progression to TB disease6,25 likely mediated through their effects on antimycobacterial immunity.26 Micronutrient supplementation (vitamins A, B complex, C, and E, as well as selenium) reduced disease recurrence by 45% in TB patients in a randomised trial in Tanzania,27 but has not been useful for the treatment of TB patients.

Intervention trials have found no benefit of zinc or vitamin A supplementation, or other micronutrient supplementation, on treatment success.28,29

This study had some strengths. It was a prospective cohort study of people after exposure to a highly infectious TB case at risk of developing a new M.tb infection. IGRA tests were used to define infection so that repeat testing was not subject to a boosting effect. The study was large enough to detect significant associations of clinical relevance, but a larger study may be necessary to detect significant associations between some micronutrients and M.tb infection. While deficiency of zinc (64%) and vitamin D (42%) among our sample population were high, selenium (<1%) and vitamin A deficiency (12%) were low.

The study did have some limitations. A relatively large number of household contacts were necessarily excluded from cohort follow-up as they were already IGRA positive due to the current or previous exposure. A pre-exposure measurement is also not possible for a household contact study. As such, IGRA converters had most likely been responding to an infection at the time of the baseline test and the infection itself may have affected their baseline results. If the adjustment of ferritin results by CRP and AGP does not fully account for low-grade inflammation, then this could have affected the validity of the ferritin result in relation to its ability to reflect iron status, as it is known to be an acute phase reactant.

However, the result for ferritin is consistent with our previously published haemoglobin finding in this cohort and with the non-significant trend with respect to total body iron.

There are several possibilities for further research. As noted above, a larger study may pick up significant associations with micronutrients other than ferritin. Because M.tb infection risk may be increased in case contacts with higher ferritin, TB case contacts may benefit from temporary reductions in iron levels by chelating agents,30 a hypothesis that could be tested first in animal models. Studies of pausing any iron supplementation in TB case contacts after a known exposure are also warranted. The success of such initiatives could be followed by exploring whether it would be useful to reduce iron levels more chronically in other populations that are highly exposed to M.tb, but this may have other negative impacts such as anaemia and tiredness.

Source: Discussion Source: Discussion Source: Discussion Source: Discussion Source: Discussion Source: Discussion

Results

Of 433 contacts recruited to the cohort with a negative IGRA at baseline,3 430 had a complete set of micronutrient measurements and 115 (27%) underwent IGRA conversion. As expected, IGRA converters were likely to be contacts of more infectious TB cases (by cough duration, sputum smear grade and advanced x-ray changes) and tended to have more exposure to their respective index case and be BCG unvaccinated (Table 1). IGRA converters had higher mean haemoglobin concentrations than persistently IGRA-negative contacts.

The two groups were otherwise reasonably well balanced by age, gender, ethnicity, smoking and diabetes status.

Table 1.

Characteristics of 430 household contacts and their 223 linked indexa TB cases

 IGRA converterPersistently IGRA negativeTotal
 n=115n=315n=430
Index case characteristics    
Age, median (IQR), y38 (28 to 51)42 (31 to 53)41 (31 to 53)
Gender:   
 Female59 (51.3)159 (50.5)218 (50.7)
 Male56 (48.7)156 (49.5)212 (49.3)
Cough duration, median (IQR), d60 (30 to 90)30 (30 to 90)30 (30 to 90)
 <2 wk11 (9.6)53 (16.8)64 (14.9)
 2 wk: 2 mo67 (58.3)173 (54.9)240 (5.8)
 >2 mo37 (32.2)89 (28.3)126 (29.3)
Highest smear grade:   
 Scanty and 1+26 (22.6)131 (41.6)157 (36.5)
 2+28 (24.4)81 (25.7)109 (25.4)
 3+61 (53.0)103 (32.7)164 (38.1)
Cavities on x-rayb56 (50.0)126 (42.1)182 (44.3)
Extent x-rayb changes, median (IQR)40 (25 to 53)35 (20 to 60)40 (25 to 55)
Contact characteristics    
Hours spent with index case, median (IQR)5 (3 to 8)3 (1 to 7)4 (1 to 8)
Sleep proximity to index case:   
 Different room93 (80.9)251 (79.7)344 (80.0)
 Same room22 (19.1)64 (20.3)86 (20.0)
Age, median (IQR), y23 (15 to 36)22 (12 to 41)23 (12 to 39)
Gender:   
 Female59 (51.3)168 (53.3)227 (52.8)
 Male56 (48.7)147 (46.7)203 (47.2)
Ethnicity:   
 Sunda103 (89.6)289 (91.7)392 (91.2)
 Other12 (10.4)26 (8.3)38 (8.8)
BCG vaccinated85 (73.9)275 (87.3)360 (83.7)
Smoking history:   
 Never74 (64.9)224 (71.1)298 (69.5)
 Current37 (32.5)76 (24.1)113 (26.3)
 Quit >6 mo ago3 (2.6)15 (4.8)18 (4.2)
Diabetesc:   
 No diabetes102 (88.7)290 (92.0)392 (91.1)
 Prediabetes7 (6.1)14 (4.4)21 (4.9)
 Diabetes6 (5.2)11 (3.5)17 (4.0)
Body mass index, median (IQR), kg/m221 (18 to 25)20 (17 to 24)20 (17 to 25)
Haemoglobin, mean (SD), g/dL14.1 (1.9)13.8 (1.6)13.9 (1.7)

Abbreviations: BCG: Bacillus Calmette: Guérin; IGRA: interferon gamma release assay; RCBG: random capillary blood glucose.

Figures are n (%) unless otherwise indicated.

a

Index cases may be represented multiple times if they have more than one contact.

b

x-ray available for detailed reading in index cases of 756 baseline IGRA-positive contacts (96.9%), 113 (97.4%) converters and 301 (95.0%) persistently IGRA-negative contacts.

c

Diabetes: no diabetes: RCBG<101 mg/dL or HbA1c<5.7%; prediabetes: HbA1c 5.7%: 6.4%; diabetes: HbA1c≥6.5%.

In the overall sample population, the prevalences of selenium deficiency and iron deficiency anaemia were low (0.7% and 3.0%, respectively), the prevalence of sTfR was fairly low (6.3%), but prevalences of zinc deficiency and vitamin D deficiency were high (63.7% and 42.2%, respectively) (Table 2). There was no statistically significant difference by IGRA conversion status in the prevalence of deficiency in any of the micronutrient measures (Table 3).

Table 2.

Proportion of TB case contacts with micronutrient deficiency at baseline by follow-up IGRA status

 IGRA converter (n=115) N (%)Persistently IGRA negative(n=315) N (%)Total N (%)p
Ferritin <12 μg/l7 (6.1)39 (12.2)46 (10.7%)0.06
Iron deficiency anaemiaa3 (2.6)10 (3.2)13 (3.0)0.76
Soluble transferrin receptor>8.3 mg/L5 (4.3)22 (7.0)27 (6.3)0.32
Total body iron<0 mg/kg7 (6.1)33 (10.5)40 (9.3)0.17
Retinol-binding protein<0.83 μmol/L14 (12.2)38 (12.1)52 (12.1)0.98
Zincb<9.9 μmol/L70 (65.4)188 (63.1)258 (63.7)0.67
Selenium≤0.82 μmol/L1 (0.9)2 (0.6)3 (0.7)0.80
25-OH vitamin D<50 nmol/L48 (41.7)133 (42.4)181 (42.2)0.91

Abbreviation: IGRA: interferon gamma release assay.

Data were adjusted for inflammation before categorisation.

a

Hb<120 g/L for females and children or <130 g/L for men, and ferritin<12 μg/L.

b

Time since last meal was unknown for 25 participants, so adjusted zinc values were known for only n=405.

Table 3.

Micronutrient biomarker* concentration by follow-up IGRA status

 IGRA converters (n=115)Persistently IGRA negative (n=315)
 Mean (SD)95% CIMean (SD)95% CI
Ferritin (ug/L)73.2 (48.3)60.9 to 77.562.4 (47.4)54.0 to 63.3
Soluble transferrin receptor (mg/L)5.55 (1.78)5.07 to 5.715.76 (1.90)5.42 to 5.82
Total body iron (mg/kg)6.65 (4.59)6.03 to 7.515.79 (4.36)5.48 to 6.35
Zinc (μmol/L)9.64 (1.05)9.71 to 10.29.69 (1.64)9.80 to 10.2
Selenium (μmol/L)1.17 (0.14)1.14 to 1.191.14 (0.14)1.13 to 1.16
Retinol-binding protein (umol/L)1.40 (0.62)1.27 to 1.501.42 (0.63)1.34 to 1.48
25-hydroxyvitamin D (vitamin D) (nmol/L)54.9 (20.9)51.0 to 58.756.0 (21.9)53.6 to 58.5

Abbreviation: IGRA: interferon gamma release assay.

*Ferritin, soluble transferin receptor, retinol-binding protein, total body iron and selenium adjusted for inflammation, and zinc adjusted for time of collection and inflammation.

In a univariable analysis that accounted for clustering by index case, there was a statistically significant positive association between ferritin concentration (adjusted for inflammation) and risk of IGRA conversion. The incidence rate ratio (IRR) for scaled ferritin was 1.17, a 17% increase in risk of converting with an increase of 1 SD of ferritin (95% CI 1.01 to 1.35; p=0.03). TBI was also positively associated with IGRA conversion, but was significant only at the α=0.1 level; there were no other statistically significant associations (Table 4).

The multivariable analysis with all micronutrient variables included only 386 participants due to missing values for time since last meal (used to adjust zinc measure) and exposure score. The IRR for scaled ferritin was 1.19, but this was no longer statistically significant (p=0.09) (Table 4). There was no evidence of associations between other micronutrient variables and IGRA conversion. A parsimonious model gave a final estimate of the association between scaled ferritin and risk of IGRA conversion as IRR=1.27, an increase of 27% with an increase of 1 SD in ferritin concentration (95% CI 1.09 to 1.47; p=0.002).

Table 4.

Univariate and multivariate associations between micronutrient biomarkers* concentration by follow-up IGRA status

MicronutrientsIGRA converters(n=115)Persistently IGRA negative (n=315)UnadjustedAdjusted
Scaled by SDMean (SD)Mean (SD)IRR95% CIpIRR Main modela95% CIp
Ferritin (ug/L), scaled1.53 (1.01)1.31 (0.99)1.171.01 to 1.350.031.190.97 to 1.460.09
Zinc (μmol/L), scaled6.40 (0.70)6.43 (1.09)0.980.85 to 1.130.770.940.80 to 1.110.46
Selenium (μmol/L), scaled8.16 (1.00)7.98 (1.00)1.130.97 to 1.320.111.050.87 to 1.260.61
RBP (umol/L), scaled2.23 (1.00)2.26 (1.00)0.980.82 to 1.170.810.870.68 to 1.120.27
25-hydroxyvitamin D (vitamin D) (nmol/L), scaled2.54 (0.97)2.60 (1.01)0.960.83 to 1.120.610.940.80 to 1.110.50
    Model 2 b 95% CI p
Soluble transferrin receptor (mg/L)2.97 (0.95)3.08 (1.02)0.910.76 to 1.090.320.970.82 to 1.140.68
    Model 3 c 95% CI  
Total body iron (mg/kg)1.50 (1.04)1.31 (0.98)1.170.96 to 1.420.121.120.92 to 1.360.25
       Model 4 d   
Ferritin (ug/L)     1.271.09 to 1.470.002

Abbreviations: BCG: Bacillus Calmette-Guerin; BMI, body mass index; IGRA: interferon gamma release assay; IRR: incidence rate ratio; RBP, retinol-binding protein.

*Ferritin, soluble transferin receptor, RBP, total body iron and selenium adjusted for inflammation, and zinc adjusted for time of collection and inflammation and scaled for comparability by dividing observations for each measure by the SD of that variable.

a

Main model using ferritin and micronutrients (Zn, Se, RBP, vitamin D) and non-nutritional variables: index case: age, gender and smear grade; contact: age, gender, BCG vaccination, smoking, BMI and exposure score. Excludes 44 observations due to missing values for adjusted zinc (n=25), exposure score (n=19) and vitamin D (n=1).

b

Model using soluble transferrin receptor and micronutrients (Zn, Se, RBP, Vit V) and non-nutritional variables: index case: age, gender and smear grade; contact: age, gender, BCG vaccination, smoking, BMI and hours spent with index case. Excludes 44 observations due to missing values.

c

Model using total body iron and micronutrients (Zn, Se, RBP, Vit V) and non-nutritional variables: index case: age, gender and smear grade; contact: age, gender, BCG vaccination, smoking, BMI and hours spent with index case. Excludes 44 observations due to missing values.

d

Final parsimonious model includes ferritin, age of contact, BCG, BMI and exposure score. Excludes 19 observations due to missing values for exposure score (n=19).

Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results

Abstract: Conclusions

The risk of developing M.tb infection, as defined by IGRA conversion, is associated with increasing ferritin. Interventions in TB case contacts to temporarily reduce iron levels, including considering withholding any iron supplementation, may be worthy of evaluation.

Source: Conclusions
Authors’ abstract

Abstract

Background

Certain micronutrient levels have been associated with the risk of developing TB disease. We explored the possible association of selected at-risk micronutrient levels with the development of Mycobacterium tuberculosis (M.tb) infection.

Methods

This cohort study in Bandung, Indonesia, followed Interferon Gamma Release Assay (IGRA) negative TB case contacts with a repeat IGRA test at 3 mo. At baseline, blood was analysed for haemoglobin, 25-hydroxyvitamin D, retinol-binding protein, C-reactive protein, alpha-1-acid glycoprotein, serum transferrin receptor (sTfR), ferritin, zinc and selenium. Total body iron was calculated using ferritin and sTfR status. Associations between case contact micronutrient concentration and IGRA conversion were estimated using Poisson regression.

Results

Of 430 contacts, 115 (27%) underwent IGRA conversion. Ferritin concentration (adjusted for inflammation) was positively associated with risk of IGRA conversion (incidence rate ratio [IRR] for ferritin=1.17; 95% CI 1.01 to 1.35; p=0.03), but other select micronutrients were not. This association held for ferritin in the final multivariable model (IRR=1.27; 95% CI 1.09 to 1.47; p=0.002).

Conclusions

The risk of developing M.tb infection, as defined by IGRA conversion, is associated with increasing ferritin. Interventions in TB case contacts to temporarily reduce iron levels, including considering withholding any iron supplementation, may be worthy of evaluation.

Read the full paper

Introduction

Historic observations suggest susceptibility to TB disease is influenced by host nutrition. For example, an x-ray survey in a German Prisoner of War camp found British prisoners, who received Red Cross rations, had a much lower rate of TB disease than Russians who did not (1.2% vs 19.0%).1 An analysis of data from a nutritional and social intervention for children in the preantibiotic era that provided stable employment, housing and nutrition for patients with TB and their families (the Papworth experiment) showed a reduction in TB disease.2

There has been very little research on the influence of nutritional status on the development of Mycobacterium tuberculosis (M.tb) infection after household exposure to a TB case. We previously reported that the risk of a new infection, defined as Interferon Gamma Release Assay (IGRA) conversion, increased 14% with every g/dL increase in haemoglobin at the time of initial screening (95% CI 1 to 30%; p=0.04).3 Iron has been shown to be important for the growth of M.tb;4 an intervention trial of vitamin D supplementation showed a minimal reduction in tuberculin skin test conversion;5 and a case control study in Peru reported an increased risk of vitamin A deficiency and TB disease.6 However, evidence of the impact of giving vitamin A or other micronutrients on the risk of developing M.tb infection is scarce.

In the present study, we therefore investigated whether any of the five micronutrients (iron, zinc, selenium, vitamin A and vitamin D) were associated with the risk of developing M.tb infection.

Methods

Study design and procedures

This cohort study followed IGRA-negative TB case contacts, aged over 5 y, of sputum smear positive TB patients in the ‘INFECT’ study platform in Bandung, Indonesia, as previously described.3 Index case characteristics were recorded and their M.tb isolates obtained. Contacts’ demographic characteristics, smoking status, medical history, symptoms and measures of exposure to respective index cases were recorded. Physical examination included assessment of a Bacillus Calmette-Guerin (BCG) vaccination scar, height and weight. Contacts underwent a QuantiFERON-TB Gold In-Tube IGRA test for M.tb infection, interpreted according to the manufacturer's instructions.

Contacts who were IGRA negative at baseline had a repeat IGRA at 14 wk, whereupon they were labelled as IGRA ‘converters’ or ‘persistently negative’. Associations of anthropometric results with IGRA conversion have been reported previously.3

Blood was drawn into a trace element-free evacuated tube (Becton Dickinson) following the International Zinc Nutrition Consultative Group procedures.7 Time of blood collection and time of the last meal were recorded before immediate transfer of the blood samples to a chilled container (−4°C) for transport to the base laboratory. Here serum was separated using trace element-free techniques,7 and aliquots frozen at −80°C before analysis or shipment on dry ice to the Department of Human Nutrition, University of Otago, New Zealand, for biomarker analysis of zinc, selenium and vitamin D, and to the laboratory of Dr J Erhardt (VitMins Laboratory, Germany) for biomarker analysis of vitamin A retinol-binding protein (RBP), iron and inflammation markers.

Haemoglobin was determined by means of a complete blood count using an automated counter (Sysmex XE 5000; Sysmex Corporation).

Laboratory procedures

Serum vitamin D (as a 25-hydroxyvitamin D) was measured by the validated bioanalytical method8 using liquid chromatography-tandem mass spectrometer (LC-MS/MS) at the Pharmocokinetic laboratory, Faculty of Medicine, Universitas Padjadjaran, Bandung. Serum 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 concentration were determined by isotope-dilution LC-MS/MS.8 In brief, 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 internal standards were reconstituted to working concentrations using spectrophotometry. Frozen serum samples were thawed, denatured with methanol-propanol containing internal standard, vortex-mixed, extracted into hexane and dried under nitrogen. The reconstituted extract was analysed by chromatography on a Base Deactivated Silica C8 High-performance liquid chromatography column, and the metabolites and internal standards were detected by electrospray ionization MS/MS in multiple-reaction monitoring mode on a Waters instrument.

Each batch contained four UTAK controls containing known concentrations of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in pooled serum sample (SRM 972, USNIST). The coefficients of variation (CV) for UTAK controls were 4% for 25-hydroxyvitamin D3 medium, 8% for 25-hydroxyvitamin D3 low, 5% for 25-hydroxyvitamin D2 medium and 11% for 25-hydroxyvitamin D2 low.

Serum was analysed in duplicate in the laboratory of Dr J Erhardt (VitMins Laboratory, Germany) for iron biomarkers ferritin and serum transferrin receptor (sTfR), vitamin A biomarker RBP, and inflammation markers C-reactive protein (CRP) and alpha-1-acid glycoprotein (AGP), by a combined sandwich ELISA technique.9 Interassay CV of a control sample (n=40) were 2.3% for ferritin, 3.6% for sTfR, 3.6% for RBP, 5.8% for CRP and 8.1% for AGP. Serum zinc and selenium were analysed by inductively coupled plasma MS (ICP-MS) (Agilent 7500ce ICP-MS; Agilent Technologies) at the University of Otago, New Zealand.

The CV for a pooled sample (n=20) and control (UTAK, Utak Laboratories Inc.; n=41) for both zinc and selenium were 1.1% and 2.3%, respectively, with the mean results for the UTAK control both within 3% of certified values.

Statistical analysis

Descriptive statistics (median and IQR or number and %) were used to describe index case and contact demographic and clinical characteristics, anthropometric measures and biomarker concentrations. Zinc values were adjusted for time since last meal, time of sample collection and time from collection to separation (in keeping with evidence of the sensitivity of zinc levels to these factors),10 using a linear regression model with ln(Zn) as the dependent variable and logged time variables as independent variables. Following this, serum ferritin, sTfR, selenium, zinc and RBP values were adjusted for the confounding effects of inflammation (with CRP and AGP), using the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia regression approach.11 Briefly, biomarkers were transformed to meet the assumptions for linear regression (loge all except ferritin, where a square root transformation was used).

A linear regression model with the transformed biomarker as the dependent variable and ln(CRP) and ln(AGP) as the independent variables was used.12 The regression coefficients of ln(CRP) and ln(AGP) were then used to calculate adjusted values of the biomarkers using a reference concentration (maximum of lowest decile) for serum CRP and AGP to avoid overadjusting the micronutrient biomarkers among individuals with low levels of inflammation. Total body iron (TBI), expressed as mg/kg body weight, was calculated using the logarithm of the ratio of adjusted sTfR to adjusted serum ferritin (SF) as follows:: [log(sTfR/SF): 2.28229]/0.1207.13

Means and 95% CIs were calculated, where appropriate, for vitamin D and adjusted concentrations for serum ferritin, sTfR, RBP, TBI, zinc and selenium.

The thresholds for defining suboptimal biomarkers were as follows (using measures adjusted for inflammation): serum ferritin <12 μg/l;14 sTfR >8.3 mg/l;9 RBP <0.83 μmol/l;15 serum zinc <9.9 μmol/l;16 and serum selenium ≤0.82 μmol/l;17 25-hydroxyvitamin D <50 nmol/l;18 TBI deficiency <0 mg/kg. Inflammation was assessed by serum CRP >5 mg/L and AGP >1 g/L, respectively.19

Associations between case contact micronutrient concentration and IGRA conversion were estimated as relative risks using Poisson regression generalised estimating equations, clustering on case.20 Robust standard errors account for the clustering in the data and the non-Poisson errors. Observations for each micronutrient variable were scaled by dividing by the overall SD for that variable. The form of the relationships were first examined using fractional polynomial models.21 Separate multivariate models were then fit for all the three measures of iron status (ferritin, sTfR and TBI).

Only the iron biomarker that explained the highest amount of the variance (R2) with IGRA conversion was included in the final multivariate model to avoid issues with multicollinearity. Initial multivariable models included known non-nutritional potential confounders (age and gender of index case and contacts, BCG vaccination, body mass index [BMI], smoking, diabetes), as well as a score reflecting degree of exposure to TB. The score was the predicted value from logistic regression of M.tb exposure variables (index case: sputum smear grade, cavities, extent of radiographic disease; contacts: hours spent with, and sleeping proximity to, the case) against IGRA results.

Model selection was performed using modified backwards selection, with age and gender of case and contact retained.

All analyses were carried out using Stata version 17 (StataCorp LLC. College Station, TX). p<0.05 (two-sided) indicated statistical significance.

Results

Of 433 contacts recruited to the cohort with a negative IGRA at baseline,3 430 had a complete set of micronutrient measurements and 115 (27%) underwent IGRA conversion. As expected, IGRA converters were likely to be contacts of more infectious TB cases (by cough duration, sputum smear grade and advanced x-ray changes) and tended to have more exposure to their respective index case and be BCG unvaccinated (Table 1). IGRA converters had higher mean haemoglobin concentrations than persistently IGRA-negative contacts.

The two groups were otherwise reasonably well balanced by age, gender, ethnicity, smoking and diabetes status.

Table 1.

Characteristics of 430 household contacts and their 223 linked indexa TB cases

 IGRA converterPersistently IGRA negativeTotal
 n=115n=315n=430
Index case characteristics    
Age, median (IQR), y38 (28 to 51)42 (31 to 53)41 (31 to 53)
Gender:   
 Female59 (51.3)159 (50.5)218 (50.7)
 Male56 (48.7)156 (49.5)212 (49.3)
Cough duration, median (IQR), d60 (30 to 90)30 (30 to 90)30 (30 to 90)
 <2 wk11 (9.6)53 (16.8)64 (14.9)
 2 wk: 2 mo67 (58.3)173 (54.9)240 (5.8)
 >2 mo37 (32.2)89 (28.3)126 (29.3)
Highest smear grade:   
 Scanty and 1+26 (22.6)131 (41.6)157 (36.5)
 2+28 (24.4)81 (25.7)109 (25.4)
 3+61 (53.0)103 (32.7)164 (38.1)
Cavities on x-rayb56 (50.0)126 (42.1)182 (44.3)
Extent x-rayb changes, median (IQR)40 (25 to 53)35 (20 to 60)40 (25 to 55)
Contact characteristics    
Hours spent with index case, median (IQR)5 (3 to 8)3 (1 to 7)4 (1 to 8)
Sleep proximity to index case:   
 Different room93 (80.9)251 (79.7)344 (80.0)
 Same room22 (19.1)64 (20.3)86 (20.0)
Age, median (IQR), y23 (15 to 36)22 (12 to 41)23 (12 to 39)
Gender:   
 Female59 (51.3)168 (53.3)227 (52.8)
 Male56 (48.7)147 (46.7)203 (47.2)
Ethnicity:   
 Sunda103 (89.6)289 (91.7)392 (91.2)
 Other12 (10.4)26 (8.3)38 (8.8)
BCG vaccinated85 (73.9)275 (87.3)360 (83.7)
Smoking history:   
 Never74 (64.9)224 (71.1)298 (69.5)
 Current37 (32.5)76 (24.1)113 (26.3)
 Quit >6 mo ago3 (2.6)15 (4.8)18 (4.2)
Diabetesc:   
 No diabetes102 (88.7)290 (92.0)392 (91.1)
 Prediabetes7 (6.1)14 (4.4)21 (4.9)
 Diabetes6 (5.2)11 (3.5)17 (4.0)
Body mass index, median (IQR), kg/m221 (18 to 25)20 (17 to 24)20 (17 to 25)
Haemoglobin, mean (SD), g/dL14.1 (1.9)13.8 (1.6)13.9 (1.7)

Abbreviations: BCG: Bacillus Calmette: Guérin; IGRA: interferon gamma release assay; RCBG: random capillary blood glucose.

Figures are n (%) unless otherwise indicated.

a

Index cases may be represented multiple times if they have more than one contact.

b

x-ray available for detailed reading in index cases of 756 baseline IGRA-positive contacts (96.9%), 113 (97.4%) converters and 301 (95.0%) persistently IGRA-negative contacts.

c

Diabetes: no diabetes: RCBG<101 mg/dL or HbA1c<5.7%; prediabetes: HbA1c 5.7%: 6.4%; diabetes: HbA1c≥6.5%.

In the overall sample population, the prevalences of selenium deficiency and iron deficiency anaemia were low (0.7% and 3.0%, respectively), the prevalence of sTfR was fairly low (6.3%), but prevalences of zinc deficiency and vitamin D deficiency were high (63.7% and 42.2%, respectively) (Table 2). There was no statistically significant difference by IGRA conversion status in the prevalence of deficiency in any of the micronutrient measures (Table 3).

Table 2.

Proportion of TB case contacts with micronutrient deficiency at baseline by follow-up IGRA status

 IGRA converter (n=115) N (%)Persistently IGRA negative(n=315) N (%)Total N (%)p
Ferritin <12 μg/l7 (6.1)39 (12.2)46 (10.7%)0.06
Iron deficiency anaemiaa3 (2.6)10 (3.2)13 (3.0)0.76
Soluble transferrin receptor>8.3 mg/L5 (4.3)22 (7.0)27 (6.3)0.32
Total body iron<0 mg/kg7 (6.1)33 (10.5)40 (9.3)0.17
Retinol-binding protein<0.83 μmol/L14 (12.2)38 (12.1)52 (12.1)0.98
Zincb<9.9 μmol/L70 (65.4)188 (63.1)258 (63.7)0.67
Selenium≤0.82 μmol/L1 (0.9)2 (0.6)3 (0.7)0.80
25-OH vitamin D<50 nmol/L48 (41.7)133 (42.4)181 (42.2)0.91

Abbreviation: IGRA: interferon gamma release assay.

Data were adjusted for inflammation before categorisation.

a

Hb<120 g/L for females and children or <130 g/L for men, and ferritin<12 μg/L.

b

Time since last meal was unknown for 25 participants, so adjusted zinc values were known for only n=405.

Table 3.

Micronutrient biomarker* concentration by follow-up IGRA status

 IGRA converters (n=115)Persistently IGRA negative (n=315)
 Mean (SD)95% CIMean (SD)95% CI
Ferritin (ug/L)73.2 (48.3)60.9 to 77.562.4 (47.4)54.0 to 63.3
Soluble transferrin receptor (mg/L)5.55 (1.78)5.07 to 5.715.76 (1.90)5.42 to 5.82
Total body iron (mg/kg)6.65 (4.59)6.03 to 7.515.79 (4.36)5.48 to 6.35
Zinc (μmol/L)9.64 (1.05)9.71 to 10.29.69 (1.64)9.80 to 10.2
Selenium (μmol/L)1.17 (0.14)1.14 to 1.191.14 (0.14)1.13 to 1.16
Retinol-binding protein (umol/L)1.40 (0.62)1.27 to 1.501.42 (0.63)1.34 to 1.48
25-hydroxyvitamin D (vitamin D) (nmol/L)54.9 (20.9)51.0 to 58.756.0 (21.9)53.6 to 58.5

Abbreviation: IGRA: interferon gamma release assay.

*Ferritin, soluble transferin receptor, retinol-binding protein, total body iron and selenium adjusted for inflammation, and zinc adjusted for time of collection and inflammation.

In a univariable analysis that accounted for clustering by index case, there was a statistically significant positive association between ferritin concentration (adjusted for inflammation) and risk of IGRA conversion. The incidence rate ratio (IRR) for scaled ferritin was 1.17, a 17% increase in risk of converting with an increase of 1 SD of ferritin (95% CI 1.01 to 1.35; p=0.03). TBI was also positively associated with IGRA conversion, but was significant only at the α=0.1 level; there were no other statistically significant associations (Table 4).

The multivariable analysis with all micronutrient variables included only 386 participants due to missing values for time since last meal (used to adjust zinc measure) and exposure score. The IRR for scaled ferritin was 1.19, but this was no longer statistically significant (p=0.09) (Table 4). There was no evidence of associations between other micronutrient variables and IGRA conversion. A parsimonious model gave a final estimate of the association between scaled ferritin and risk of IGRA conversion as IRR=1.27, an increase of 27% with an increase of 1 SD in ferritin concentration (95% CI 1.09 to 1.47; p=0.002).

Table 4.

Univariate and multivariate associations between micronutrient biomarkers* concentration by follow-up IGRA status

MicronutrientsIGRA converters(n=115)Persistently IGRA negative (n=315)UnadjustedAdjusted
Scaled by SDMean (SD)Mean (SD)IRR95% CIpIRR Main modela95% CIp
Ferritin (ug/L), scaled1.53 (1.01)1.31 (0.99)1.171.01 to 1.350.031.190.97 to 1.460.09
Zinc (μmol/L), scaled6.40 (0.70)6.43 (1.09)0.980.85 to 1.130.770.940.80 to 1.110.46
Selenium (μmol/L), scaled8.16 (1.00)7.98 (1.00)1.130.97 to 1.320.111.050.87 to 1.260.61
RBP (umol/L), scaled2.23 (1.00)2.26 (1.00)0.980.82 to 1.170.810.870.68 to 1.120.27
25-hydroxyvitamin D (vitamin D) (nmol/L), scaled2.54 (0.97)2.60 (1.01)0.960.83 to 1.120.610.940.80 to 1.110.50
    Model 2 b 95% CI p
Soluble transferrin receptor (mg/L)2.97 (0.95)3.08 (1.02)0.910.76 to 1.090.320.970.82 to 1.140.68
    Model 3 c 95% CI  
Total body iron (mg/kg)1.50 (1.04)1.31 (0.98)1.170.96 to 1.420.121.120.92 to 1.360.25
       Model 4 d   
Ferritin (ug/L)     1.271.09 to 1.470.002

Abbreviations: BCG: Bacillus Calmette-Guerin; BMI, body mass index; IGRA: interferon gamma release assay; IRR: incidence rate ratio; RBP, retinol-binding protein.

*Ferritin, soluble transferin receptor, RBP, total body iron and selenium adjusted for inflammation, and zinc adjusted for time of collection and inflammation and scaled for comparability by dividing observations for each measure by the SD of that variable.

a

Main model using ferritin and micronutrients (Zn, Se, RBP, vitamin D) and non-nutritional variables: index case: age, gender and smear grade; contact: age, gender, BCG vaccination, smoking, BMI and exposure score. Excludes 44 observations due to missing values for adjusted zinc (n=25), exposure score (n=19) and vitamin D (n=1).

b

Model using soluble transferrin receptor and micronutrients (Zn, Se, RBP, Vit V) and non-nutritional variables: index case: age, gender and smear grade; contact: age, gender, BCG vaccination, smoking, BMI and hours spent with index case. Excludes 44 observations due to missing values.

c

Model using total body iron and micronutrients (Zn, Se, RBP, Vit V) and non-nutritional variables: index case: age, gender and smear grade; contact: age, gender, BCG vaccination, smoking, BMI and hours spent with index case. Excludes 44 observations due to missing values.

d

Final parsimonious model includes ferritin, age of contact, BCG, BMI and exposure score. Excludes 19 observations due to missing values for exposure score (n=19).

Discussion

To the best of our knowledge, this is the first study investigating multiple micronutrient status and risk of developing M.tb infection. Our findings show that, in addition to the previously identified association of increasing haemoglobin with IGRA conversion, there is also a positive association for ferritin. There were no associations found between zinc, selenium, vitamin A or vitamin D status and IGRA conversion.

The association of increasing ferritin with IGRA conversion is consistent with studies that have demonstrated iron is a nutritional requirement of M.tb infection.4 We also note that, with respect to TB disease, the iron transporter natural resistance-associated macrophage protein (NRAMP) is strongly associated with susceptibility.22 In a Tanzanian study, high plasma ferritin was associated with increased treatment failure in TB cases and low ferritin levels were associated with increased mortality.23 Increasing hepcidin, a regulator of iron homeostasis, levels correlated with increasing time to culture negativity in Japanese TB cases.24 Together, these findings indicate that increased availability of iron increases the capacity of M.tb to cause infection as well as disease, consistent with the pathogen's nutritional dependency on iron.

We found no association with IGRA conversion for the remaining micronutrients investigated. However, there is some reason to believe that other micronutrient supplementation may have a role in relation to both M.tb infection and disease, at least in certain situations. An intervention trial in vitamin D-deficient children in Mongolia showed a borderline significant reduction in tuberculin skin test conversion over 6 mo: five (11%) children receiving vitamin D supplementation underwent conversion compared with 11 (27%) receiving placebo (RR 0.41; 95% CI 0.16 to 1.09; p=0.06).5 Vitamin A and selenium deficiencies have been associated with progression to TB disease6,25 likely mediated through their effects on antimycobacterial immunity.26 Micronutrient supplementation (vitamins A, B complex, C, and E, as well as selenium) reduced disease recurrence by 45% in TB patients in a randomised trial in Tanzania,27 but has not been useful for the treatment of TB patients.

Intervention trials have found no benefit of zinc or vitamin A supplementation, or other micronutrient supplementation, on treatment success.28,29

This study had some strengths. It was a prospective cohort study of people after exposure to a highly infectious TB case at risk of developing a new M.tb infection. IGRA tests were used to define infection so that repeat testing was not subject to a boosting effect. The study was large enough to detect significant associations of clinical relevance, but a larger study may be necessary to detect significant associations between some micronutrients and M.tb infection. While deficiency of zinc (64%) and vitamin D (42%) among our sample population were high, selenium (<1%) and vitamin A deficiency (12%) were low.

The study did have some limitations. A relatively large number of household contacts were necessarily excluded from cohort follow-up as they were already IGRA positive due to the current or previous exposure. A pre-exposure measurement is also not possible for a household contact study. As such, IGRA converters had most likely been responding to an infection at the time of the baseline test and the infection itself may have affected their baseline results. If the adjustment of ferritin results by CRP and AGP does not fully account for low-grade inflammation, then this could have affected the validity of the ferritin result in relation to its ability to reflect iron status, as it is known to be an acute phase reactant.

However, the result for ferritin is consistent with our previously published haemoglobin finding in this cohort and with the non-significant trend with respect to total body iron.

There are several possibilities for further research. As noted above, a larger study may pick up significant associations with micronutrients other than ferritin. Because M.tb infection risk may be increased in case contacts with higher ferritin, TB case contacts may benefit from temporary reductions in iron levels by chelating agents,30 a hypothesis that could be tested first in animal models. Studies of pausing any iron supplementation in TB case contacts after a known exposure are also warranted. The success of such initiatives could be followed by exploring whether it would be useful to reduce iron levels more chronically in other populations that are highly exposed to M.tb, but this may have other negative impacts such as anaemia and tiredness.

Acknowledgements

The authors are grateful for the dedicated field, laboratory and data management team who recruited the cohort, including Andini Cahya Nurani, Novianti, Deni, Wiwik Pratiwi, Dody Taufik Akbar, Emira Diandini, Dwi Febni Ratnaningsih, Fitria Utami, Inas Kathina, Yusak Sastra Atmaja, Nuni Haeruni, Anbarunik Puteri Danthin, Harold Eka Atmaja, Alif Al Birru, Nopi Susilawati and Runi Rahmawati. Thanks also to Dr Agnes Rengga Indrati: head of the Immunology laboratory. The cooperation of the Index case (TANDEM) study team, particularly co-ordinator Raspati C.

Koesoemadinata, Lidya Chaidir, Jessi Annisa and Ria Windyani, is acknowledged. Thanks to Michelle Harper and Malcolm Reid in the Department of Human Nutrition laboratory at the University of Otago, New Zealand. Thanks also to the participants and parents/guardians in this study.

Authors’ contributions

AJV, RvC, RR, PCH and BA conceived the study and designed the study protocol; LA and AJV carried out the study implementation; LH, HEA, AvL and JEU provided laboratory analysis and interpretation; AJV, KS and SMM analysed the data; AJV and PCH drafted the manuscript. All authors reviewed and approved the final draft of the manuscript.

Funding

AV was supported by a New Zealand Health Research Council Clinical Training Research Fellowship. Cohort recruitment was funded by the University of Otago and Mercy Hospital, Dunedin, New Zealand. Micronutrient analysis was supported by a University of Otago Research Grant. Qiagen donated the QuantiFERON test materials used in the study. Enrollment clinical management and laboratory examination of index cases was conducted in the TANDEM project (www.tandem-fp7.eu), which is supported by the European Union's Seventh Framework Programme (FP7/2007 to 2013) under Grant Agreement Number 305279.

Competing interests

The authors have no conflicts of interest to declare.

Ethical approval

The study was approved by the Health Research Ethics Committee Universitas Padjadjaran (14/UN6.C2.1.2/KEPK/PN/2014) and the Southern Health and Disability Ethics Committee New Zealand (13/STH/132). All participants gave written informed consent.

Data availability

The data underlying this article will be shared upon reasonable request to the corresponding author.

References

1 Schaible  UE , Kaufmann  SHE.  Malnutrition and infection: complex mechanisms and global impacts . PLoS Med . 2007 ;4 (5 ):e115 . 17472433 10.1371/journal.pmed.0040115 PMC1858706
2 Bhargava  A , Pai  M , Bhargava  M  et al.  Can social interventions prevent tuberculosis? The Papworth experiment (1918 to 1943) revisited . Am J Resp Crit Care Med . 2012 ;186 (5 ):442Not reported9 . 22773730 10.1164/rccm.201201-0023OC
3 Verrall  AJ , Alisjahbana  B , Apriani  L  et al.  Early clearance of mycobacterium tuberculosis: the INFECT case contact cohort study in Indonesia . J Infect Dis . 2020 ;221 (8 ):1351Not reported60 . 31298280 10.1093/infdis/jiz168
4 Boelaert  JR , Vandecasteele  SJ , Appelberg  R  et al.  The effect of the host's iron status on tuberculosis . J Infect Dis . 2007 ;195 (12 ):1745Not reported53 . 17492589 10.1086/518040
5 Ganmaa  D , Giovannucci  E , Bloom  BR  et al.  Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial . Am J Clin Nutr . 2012 ;96 (2 ):391Not reported6 . 22760564 10.3945/ajcn.112.034967 PMC3396446
6 Aibana  O , Franke  MF , Huang  C-C  et al.  Impact of vitamin A and carotenoids on the risk of tuberculosis progression . Clin Infect Dis . 2017 ;65 (6 ):900Not reported9 . 28531276 10.1093/cid/cix476 PMC5848231
7 Brown  KH , Rivera  JA , Bhutta  Z  et al.  International Zinc Nutrition Consultative Group (IZiNCG) technical document# 1. Assessment of the risk of zinc deficiency in populations and options for its control . Food Nutr Bull . 2004 ;25 (1, Suppl 2 ):S99Not reportedS203 . 18046856
8 Maunsell  Z , Wright  DJ , Rainbow  SJ.  Routine isotope-dilution liquid chromatography: tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3 . Clin Chem . 2005 ;51 (9 ):1683Not reported90 . 16020493 10.1373/clinchem.2005.052936
9 Erhardt  JG , Estes  JE , Pfeiffer  CM  et al.  Combined measurement of ferritin, soluble transferrin receptor, retinol binding protein, and C-reactive protein by an inexpensive, sensitive, and simple sandwich enzyme-linked immunosorbent assay technique . J Nutr . 2004 ;134 (11 ):3127Not reported32 . 15514286 10.1093/jn/134.11.3127
10 Arsenault  J , Wuehler  S , De Romana  D  et al.  The time of day and the interval since previous meal are associated with plasma zinc concentrations and affect estimated risk of zinc deficiency in young children in Peru and Ecuador . Eur J Clin Nutr . 2011 ;65 (2 ):184Not reported90 . 20978526 10.1038/ejcn.2010.234
11 Suchdev  PS , Namaste  SM , Aaron  GJ  et al.  Overview of the biomarkers reflecting inflammation and nutritional determinants of anemia (BRINDA) project . Adv Nutr . 2016 ;7 (2 ):349Not reported56 . 26980818 10.3945/an.115.010215 PMC4785469
12 Diana  A , Haszard  JJ , Purnamasari  DM  et al.  Iron, zinc, vitamin A and selenium status in a cohort of Indonesian infants after adjusting for inflammation using several different approaches . Br J Nutr . 2017 ;118 (10 ):830Not reported9 . 29189196 10.1017/S0007114517002860
13 Pfeiffer  CM , Looker  AC.  Laboratory methodologies for indicators of iron status: strengths, limitations, and analytical challenges . Am J Clin Nutr . 2017 ;106 (Suppl. 6 ):1606SNot reported14 S. 29070545 10.3945/ajcn.117.155887 PMC5701713
14 World Health Organization . Serum Ferritin Concentrations for the Assessment of Iron Status and Iron Deficiency in Populations . Geneva, Switzerland: World Health Organization; 2011 .
15 Engle-Stone  R , Haskell  MJ , Ndjebayi  AO  et al.  Plasma retinol-binding protein predicts plasma retinol concentration in both infected and uninfected Cameroonian women and children . J Nutr . 2011 ;141 (12 ):2233Not reported41 . 22049292 10.3945/jn.111.145805
16 Hess  SY , Peerson  JM , King  JC  et al.  Use of serum zinc concentration as an indicator of population zinc status . Food Nutr Bull . 2007 ;28 (3, Suppl.3 ):S403Not reportedS29 . 17988005 10.1177/15648265070283S303
17 Thomson  C.  Assessment of requirements for selenium and adequacy of selenium status: a review . Eur J Clin Nutr . 2004 ;58 (3 ):391Not reported402 . 14985676 10.1038/sj.ejcn.1601800
18 Malabanan  A , Veronikis  I , Holick  M.  Redefining vitamin D insufficiency . Lancet . 1998 ;351 (9105 ):805Not reported6 . 10.1016/s0140-6736(05)78933-9 9519960
19 Thurnham  DI , McCabe  LD , Haldar  S  et al.  Adjusting plasma ferritin concentrations to remove the effects of subclinical inflammation in the assessment of iron deficiency: a meta-analysis . Am J Clin Nutr . 2010 ;92 (3 ):546Not reported55 . 20610634 10.3945/ajcn.2010.29284
20 Zou  G.  A modified poisson regression approach to prospective studies with binary data . Am J Epidemiol . 2004 ;159 (7 ):702Not reported6 . 15033648 10.1093/aje/kwh090
21 Royston  P , Altman  DG.  Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling . J R Stat Soc C: Appl Stat . 1994 ;43 (3 ):429Not reported53 .
22 Velez  D , Hulme  W , Myers  J  et al.  Association of SLC11A1 with tuberculosis and interactions with NOS2A and TLR2 in African-Americans and Caucasians . Int J Tuberc Lung Dis . 2009 ;13 (9 ):1068Not reported76 . 19723394 PMC2902362
23 Isanaka  S , Aboud  S , Mugusi  F  et al.  Iron status predicts treatment failure and mortality in tuberculosis patients: a prospective cohort study from Dar es Salaam, Tanzania . PLoS One . 2012 ;7 (5 ):e37350 . 22606361 10.1371/journal.pone.0037350 PMC3350480
24 Tashiro  K , Yamamoto  M , Ushio  R  et al.  Hepcidin exerts a negative immunological effect in pulmonary tuberculosis without HIV co-infection, prolonging the time to culture-negative . Int J Infect Dis . 2019 ;86 :47Not reported54 . 31252187 10.1016/j.ijid.2019.06.023
25 Shor-Posner  G , Miguez  M-J , Pineda  L  et al.  Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy . J Acq Immune Defic Syndr . 2002 ;29 (2 ):169Not reported73 . 10.1097/00042560-200202010-00010 11832687
26 Botella  H , Peyron  P , Levillain  F  et al.  Mycobacterial P1-type ATPases mediate resistance to zinc poisoning in human macrophages . Cell Host Microbe . 2011 ;10 (3 ):248Not reported59 . 21925112 10.1016/j.chom.2011.08.006 PMC3221041
27 Villamor  E , Mugusi  F , Urassa  W  et al.  A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis . J Infect Dis . 2008 ;197 (11 ):1499Not reported505 . 18471061 10.1086/587846 PMC2564793
28 Grobler  L , Nagpal  S , Sudarsanam  TD  et al.  Nutritional supplements for people being treated for active tuberculosis . Cochrane Database Syst Rev . 2016 ;2016 (6 ):Cd006086 . 27355911 10.1002/14651858.CD006086.pub4 PMC4981643
29 Wagnew  F , Alene  KA , Eshetie  S  et al.  Effects of zinc and vitamin A supplementation on prognostic markers and treatment outcomes of adults with pulmonary tuberculosis: a systematic review and meta-analysis . BMJ Glob Health . 2022 ;7 (9 ):e008625 . 10.1136/bmjgh-2022-008625 PMC9490634 36130775
30 Schaible  UE , Kaufmann  SH.  Iron and microbial infection . Nat Rev Micro . 2004 ;2 (12 ):946Not reported53 . 10.1038/nrmicro1046 15550940
Publication and source details

Original title: Micronutrient status and risk of Mycobacterium tuberculosis infection in Indonesian tuberculosis case contacts

Ayesha J Verrall; Lisa Houghton; Lika Apriani; Harold E Atmaja; Arjan van Laarhoven; James E Ussher; Rovina Ruslami; Katrina Sharples; Susan McAllister; Reinout van Crevel; Philip C Hill; Bachti Alisjahbana

Transactions of the Royal Society of Tropical Medicine and Hygiene · 2025

Corresponding author: Tel: +64 21 279 7214; E-mail: Philip.hill@otago.ac.nz© The Author(s) 2025. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.2025https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. New Zealand Health Research Council Clinical Training Research Fellowship University of Otago10.13039/100008247 Mercy Hospital European Union10.13039/501100000780 305279

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T02:29:38.703598+00:00

DOI: 10.1093/trstmh/trae140 · PMC11960743